U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H4O4.Fe
Molecular Weight 171.917
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of FERROUS SUCCINATE

SMILES

[Fe++].[O-]C(=O)CCC([O-])=O

InChI

InChIKey=MDXRFOWKIZPNTA-UHFFFAOYSA-L
InChI=1S/C4H6O4.Fe/c5-3(6)1-2-4(7)8;/h1-2H2,(H,5,6)(H,7,8);/q;+2/p-2

HIDE SMILES / InChI
Molecular Formula C4H4O4
Molecular Weight 116.0722
Charge -2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE
Molecular Formula Fe
Molecular Weight 55.845
Charge 2
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description
Curator's Comment: description was created based on several sources, including https://www.ncbi.nlm.nih.gov/pubmed/672678 | https://www.ncbi.nlm.nih.gov/pubmed/27138526 | https://www.ncbi.nlm.nih.gov/pubmed/20685224 | https://www.ncbi.nlm.nih.gov/pubmed/26911730

Iron(II) oxide or ferrous oxide is the inorganic compound with the formula FeO. One of several iron oxides, it is a black-colored powder that is sometimes confused with rust, which consists of hydrated iron(III) oxide (ferric oxide). Iron(II) oxide also refers to a family of related non-stoichiometric compounds, which are typically iron deficient with compositions ranging from Fe0.84O to Fe0.95O. Iron(II) oxide makes up approximately 9% of the Earth's mantle. Within the mantle, it may be electrically conductive, which is a possible explanation for perturbations in Earth's rotation not accounted for by accepted models of the mantle's properties. Iron(II) oxide is used as a pigment. It is FDA-approved for use in cosmetics and it is used in some tattoo inks. It can also be used as a phosphate remover from home aquaria.

Originator

Approval Year

1921
1447
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Not Provided
503
Unknown

Approved Use

Unknown
Palliative
Not Provided
503
Unknown

Approved Use

Unknown
Primary
Approved
8360
Ferro Sanol Duodenal

Approved Use

Ferro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia.
Curative
Approved
8360
RADIOGARDASE

Approved Use

Insoluble Prussian blue is indicated for treatment of patients with known or suspected internal contamination with radioactive cesium and/or radioactive or non-radioactive thallium to increase their rates of elimination.

Launch Date

1.06496642E12
PubMed

PubMed

TitleDatePubMed
FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS.
1932 Jul 1
FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS.
1932 Nov 11
THE ADMINISTRATION OF FERROUS IODIDE AND LINOLEIC ACID TO RATS DEPRIVED OF VITAMIN A.
1932 Sep 30
THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA.
1937 Jul
[Ferrous lactate as an oral iron preparation for therapeutic use].
1954 Nov 27
[FERROUS ASPARTATE IN THERAPY].
1964 Jan 1
[Historical notes on the therapy of depression].
1986 Nov 22
Determination of water in ferrous lactate by near infrared reflectance spectroscopy with a fibre-optic probe.
1997 Oct
Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study.
2009 Nov 15
Effect of abomasal ferrous lactate infusion on phosphorus absorption in lactating dairy cows.
2013 Jul
Synthesis of phosphabenzenes by an iron-catalyzed [2+2+2] cycloaddition reaction of diynes with phosphaalkynes.
2015 Jun 22
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example.
2017 Jul 5
Continuous sulfidogenic wastewater treatment with iron sulfide sludge oxidation and recycle.
2017 May 1
Patents

Patents

CN105565963
37
US20020127665
37
US2009028810
37
US20150202224
37
US2877253
37
US3091626
37
US5534268
37
US6407138
37
US8080520
37
US8802114
37

Sample Use Guides

In Vivo Use Guide
Unknown
Route of Administration: Unknown
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Thu Jul 06 02:01:24 UTC 2023
Edited
by admin
on Thu Jul 06 02:01:24 UTC 2023
Record UNII
818ZYK7N91
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
FERROUS SUCCINATE
MART.   MI   WHO-DD  
Common Name English
IRON SUCCINATE (FE(O4C4H4))
Common Name English
CEREVON
Code English
FERROMYN
Brand Name English
SUCCINIC ACID, IRON(2+) SALT (1:1)
Common Name English
Ferrous succinate [WHO-DD]
Common Name English
FERROUS SUCCINATE [MI]
Common Name English
IRON(II) SUCCINATE
Systematic Name English
FERRLECIT 2
Brand Name English
BUTANEDIOIC ACID, IRON(2+) SALT (1:1)
Common Name English
FERROUS SUCCINATE [MART.]
Common Name English
Classification Tree Code System Code
WHO-ATC B03AA06
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
WHO-VATC QB03AA06
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
Code System Code Type Description
EVMPD
SUB13875MIG
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
DRUG BANK
DB14489
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
RXCUI
24946
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY RxNorm
FDA UNII
818ZYK7N91
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
SMS_ID
100000078473
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
PUBCHEM
10464762
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
MERCK INDEX
M5353
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY Merck Index
DRUG CENTRAL
4544
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
CAS
10030-90-7
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
MESH
C022943
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
ECHA (EC/EINECS)
233-082-3
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
ChEMBL
CHEMBL3707232
Created by admin on Thu Jul 06 02:01:24 UTC 2023 , Edited by admin on Thu Jul 06 02:01:24 UTC 2023
PRIMARY
Related Record Type Details
Structure of FERROUS CATION
PARENT -> SALT/SOLVATE
Structure of SUCCINIC ACID
PARENT -> SALT/SOLVATE
Related Record Type Details
Structure of FERROUS CATION
ACTIVE MOIETY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966